Citation Impact
Citing Papers
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
A single low dose of cadmium exposure induces benign prostate hyperplasia like condition in rat: A novel benign prostate hyperplasia rodent model
2014
Lipid peroxides and atherosclerosis.
1989
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Altered Expression of Hepatic Cytochromes P-450 in Mice Deficient in One or More mdr1 Genes
2000
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
P450 Enzymes
1992
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Accelerated degradation of mislocalized UDP–glucuronosyltransferase family 1 (UGT1) proteins in Gunn rat hepatocytes
2002 StandoutNobel
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
1992
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D
1994
Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events
2006
Anti-GOR and hepatitis C virus in autoimmune liver diseases
1992
Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs
2000
Nonalcoholic Fatty Liver Disease
2002 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis
1991 StandoutNobel
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
A silicon transporter in rice
2006 StandoutNature
Diagnosis and Management of Autoimmune Hepatitis
2010
Drug-Induced Hepatotoxicity
2003 Standout
Autoimmune Hepatitis, From Mechanisms to Therapy
2006
Protein Oxidation in Aging, Disease, and Oxidative Stress
1997 Standout
Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
1989
Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis
2005
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Liver/Kidney Microsome Antibody Type 1 and Hepatitis C Virus Infection
1992
Mass spectrometry‐based absolute quantification of microsomal cytochrome P450 2D6 in human liver
2009
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
1990
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Acute Pancreatitis
1994 Standout
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
2004
Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain
2001
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
Animal models for autoimmune hepatitis
2006
Bioactivation of Flutamide Metabolites by Human Liver Microsomes
2008
Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
1997
Autoimmunity in hepatitis C and D virus infection
1996
LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.
1991
Requirements and Challenges of a Preclinical Autoimmune Hepatitis Mouse Model
2011
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Vitamin E Consumption and the Risk of Coronary Disease in Women
1993 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Lipid peroxidation: its mechanism, measurement, and significance
1993 Standout
Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
2004
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
1991
[37] Carbonyl assays for determination of oxidatively modified proteins
1994 Standout
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z‐4‐hydroxy‐tamoxifen in human liver
2002
Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune Hepatitis
1993
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels
1989
Role of reactive oxygen metabolites in experimental colitis.
1990
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Antioxidant properties of phenolic compounds
1997 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection
2008
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998
Immunology and the liver
1991
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
1973
MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
1997
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic Life
2006 Standout
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Dietary silicon and bone health
2005
Effects of interleukin 1α on the activities and gene expressions of the cytochrome p450iid subfamily
1992
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
NCLX is an essential component of mitochondrial Na+/Ca2+exchange
2009
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
2001
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
PolymorphicCYP2B6: Molecular Mechanisms and Emerging Clinical Significance
2007
Infarcts of the Pancreas
1958
Works of J Loeper being referenced
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
1989
Nilutamide inhibits mephenytoin 4-hydroxylation in untreated male rats and in human liver microsomes
1991
Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
1993
[Hypertensive disease with multiple infarcts and predominant pancreatic localization].
1954
Superoxide dismutase in the treatment of post-radiotherapeutic necrosis and of Crohn's disease.
1981
[Fatty acids and lipid peroxidation in experimental atheroma in the rabbit. Role played by silicon].
1984
Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat.
1994
Vesicular Transport of Newly Synthesized Cytochromes P4501A to the Outside of Rat Hepatocyte Plasma Membranes
2000
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.
1988
[Study of mixed hyperlipemia with a distinct excess of beta and pre-beta lipoproteins (78 cases)].
1971
[Study of lipid peroxidation by the assay of malondialdehyde in human and experimental atheroma].
1986
Lipid peroxidation and protective enzymes during the course of myocardial infarction
1987
The antiatheromatous action of silicon
1979